Overview

Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward

Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and tolerability of zotepine versus Risperidone in aggressive schizophrenic patients.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Astellas Pharma Taiwan, Inc.
Treatments:
Risperidone
Zotepine